Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,970 public trials 1,744 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Evaluation of Galantamine in the Treatment of Alzheimer's Disease

NCT00000172

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • James L. Frey, M.D., Ltd. Scottsdale, Arizona, United States
  • East Bay Neurology Berkeley, California, United States
  • University of Southern California Los Angeles, California, United States
View all 55 locations
View Trial Details
Completed

Study of Melatonin: Sleep Problems in Alzheimer's Disease

NCT00000171

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of California Irvine Institute for Brain Aging and Dementia Irvine, California, United States
  • University of California, San Diego La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT06220201

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Local Institution - 0011 Birmingham, Alabama, United States
  • University of California, Irvine Irvine, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

NCT07246941

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Hospital Britanico de Buenos Aires Ciudad Autonoma Bs As, Argentina
  • Westmead Hospital Westmead, New South Wales, Australia
  • Monash Health Clayton, Victoria, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details

Related conditions